“ChemBioPharm pursues interdisciplinary researches in the areas of bioorganic chemistry, biomedical engineering and nanotechnologies. A major focus is the study and development of novel bioinspired materials to i) deliver drugs (peptides, proteins, nucleic acids…), ii) construct advanced biomaterials for regenerative medicine and iii) discover novel therapeutic nucleic acids. We are currently exploring the underlying fundamental molecular and supramolecular principles of hybrid amphiphiles, including nucleolipids, glycosyl-nucleolipids, lipid oligonucleotides bioconjugates.”
Philippe Barthélémy Head of ChemBioPharm
